Source: FDA, National Drug Code (US) Revision Year: 2019
ANTHIM is indicated in adult and pediatric patients for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs.
ANTHIM is indicated for prophylaxis of inhalational anthrax due to B. anthracis when alternative therapies are not available or not appropriate [see Indications and Usage (1.2)].
ANTHIM should only be used for prophylaxis when its benefit for prevention of inhalational anthrax outweighs the risk of hypersensitivity and anaphylaxis [see Warnings and Precautions (5.1)].
The effectiveness of ANTHIM is based solely on efficacy studies in animal models of inhalational anthrax. It is not ethical or feasible to conduct controlled clinical trials with intentional exposure of humans to anthrax [see Clinical Studies (14)].
Safety and PK of ANTHIM have been studied in adult healthy volunteers. There have been no studies of safety or PK of ANTHIM in the pediatric population. A population PK approach was used to derive intravenous infusion dosing regimens that are predicted to provide pediatric patients with exposure comparable to the observed exposure in adults [see Use in Specific Populations (8.4)].
ANTHIM binds to the protective antigen (PA) component of B. anthracis toxin; it does not have direct antibacterial activity. ANTHIM is not expected to cross the blood-brain barrier and does not prevent or treat meningitis. ANTHIM should be used in combination with appropriate antibacterial drugs.
Table 1. Recommended Pediatric Dose of ANTHIM (weight-based dosing):
Body Weight | Dose |
---|---|
Greater than 40 kg | 16 mg/kg |
Greater than 15 kg to 40 kg | 24 mg/kg |
Less than or equal to 15 kg | 32 mg/kg |
There have been no studies of the safety or PK of ANTHIM conducted in the pediatric population. The dosing recommendations in Table 1 are derived from simulations using a population PK approach designed to match the observed adult exposure to ANTHIM at a 16 mg/kg dose [see Use in Specific Populations (8.4)].
Important Preparation Instructions:
Table 2. ANTHIM Dose, Total Infusion Volume and Infusion Rate by Body Weight:
Body Weight (weight-based dosing) | Total Infusion Volume | Infusion Rate |
---|---|---|
Greater than 40 kg or adult (16 mg/kg) | ||
Greater than 40 kg | 250 mL | 167 mL/hr |
Greater than 15 kg to 40 kg (24 mg/kg) | ||
31 kg to 40 kg | 250 mL | 167 mL/hr |
16 kg to 30 kg | 100 mL | 67 mL/hr |
15 kg or less (32 mg/kg) | ||
11 kg to 15 kg | 100 mL | 67 mL/hr |
5 kg to 10 kg | 50 mL | 33.3 mL/hr |
3.1 kg to 4.9 kg | 25 mL | 17 mL/hr |
2.1 kg to 3 kg | 20 mL | 13.3 mL/hr |
1.1 kg to 2 kg | 15 mL | 10 mL/hr |
1 kg or less | 7 mL | 4.7 mL/hr |
Preparation and Dilution in Bag for Infusion:
Preparation and Dilution in Syringe for Infusion:
There is no clinical experience with overdosage of ANTHIM. In case of overdosage, monitor patients for any signs or symptoms of adverse effects.
Store in refrigerator at 2°C to 8°C (36°F to 46°F) in original carton to protect from light. Do Not Freeze. Do Not Shake.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.